Irbesartan Tablet
Product Images NDC 70518-2245

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 70518-2245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irbesartanfigure3

The text describes a table or graph showing the cumulative event rate expressed as a percentage for different treatments or conditions, including 'oaran v pacebo' with a rate of 0.50%, 'einan v Ariadipne' with a rate of 0.77%, and several follow-up periods expressed in months.*

FDA Label Image

Remedy_label (Remedy Label)

Irbesartan is a prescription drug manufactured by Camber Pharma, Inc. It is indicated for the treatment of certain heart diseases. It comes with a package insert that contains detailed directions for use. The drug should be kept out of the reach of children and stored in a cool, dry place. Remedial Repack Inc. re-packages the medication.*

FDA Label Image

Image1

FDA Label Image

Image2

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.